Vale S.A. (BCBA:VALE)

Verve Therapeutics Revenue

Vale S.A. had revenue of 47.97B BRL in the quarter ending June 30, 2025, a decrease of -7.28%. This brings the company's revenue in the last twelve months to 198.07B, down -5.72% year-over-year. In the year 2024, Vale S.A. had annual revenue of 206.01B, down -0.99%.

• Revenue (ttm): 198.07B BRL
• Revenue Growth: -5.72%
• P/S Ratio: 1.39
• Revenue / Employee: 3.07M BRL
• Employees: 64,616
• Market Cap: 54.94T USD

Revenue Chart

* This company reports financials in BRL.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	206.01B	-2.06B	-0.99%
Dec 31, 2023	208.07B	-18.44B	-8.14%
Dec 31, 2022	226.51B	-67.02B	-22.83%
Dec 31, 2021	293.52B	87.43B	42.42%
Dec 31, 2020	206.10B	61.46B	42.50%